These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1725999)

  • 1. Expanding the role of calcium antagonists in hypertension. First International Lacidipine Symposium, Marbella, Spain, September 7-8, 1990.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-99. PubMed ID: 1725999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Third generation of calcium antagonists: focus on lacidipine].
    Sidorenko BA; Stetsenko TM; Preobrazhenskiĭ DV; Savchenko MV; Soplevenko AV; Shabaeva EN
    Kardiologiia; 2002; 42(12):81-90. PubMed ID: 12494025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium antagonists in hypertension: similarities and differences. Satellite symposium to the 14th scientific meeting of the International Society of Hypertension. Madrid, Spain, 19 June 1992.
    J Hypertens Suppl; 1993 Mar; 11(1):S1-69. PubMed ID: 8097764
    [No Abstract]   [Full Text] [Related]  

  • 5. Symposium on calcium antagonists in hypertension. Puerto Vallarta, Mexico, September 12-14, 1985.
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):1S-162S. PubMed ID: 3794761
    [No Abstract]   [Full Text] [Related]  

  • 6. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists into the nineties: appraisal and future trends. Verapamil satellite symposium to the 25th anniversary International Symposium on Calcium Antagonists. Basel, Switzerland, February 12, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S1-82. PubMed ID: 2475675
    [No Abstract]   [Full Text] [Related]  

  • 8. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists in hypertension. 25th anniversary international symposium. Basel, Switzerland, February 11-12, 1988.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S1-224. PubMed ID: 2468887
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium antagonists in the treatment of hypertension. An international symposium held in Basel, Switzerland, February 10-12, 1988.
    Widimský J; Uhlír O
    Cor Vasa; 1988; 30(5):376-80. PubMed ID: 2852575
    [No Abstract]   [Full Text] [Related]  

  • 11. The Management of Hypertension and Prevention of Cardiac Complications Using Calcium Antagonists. Proceedings of the 1st International Nifedipine GITS Symposium, Cannes, February 28, 1992 and of a satellite symposium to the 14th ISH Congress, Madrid, June 14, 1992.
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S1-66. PubMed ID: 7692144
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium antagonists: first-line partner for antihypertensive care. Third International Nitrendipine Symposium. Basel, Switzerland, February 10, 1988. Proceedings.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S1-187. PubMed ID: 2468845
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lacidipine: a new third generation calcium channel blocker].
    Vertkin AL; Topolianskiĭ AV
    Kardiologiia; 2002; 42(2):100-3. PubMed ID: 14587530
    [No Abstract]   [Full Text] [Related]  

  • 14. A symposium: The Role of Calcium Antagonists in Hypertension. New York, New York, October 11, 1991.
    Am J Cardiol; 1992 Apr; 69(13):1E-42E. PubMed ID: 1349454
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety profile of lacidipine: a review of clinical data.
    Endersby CA; Brown EG; Perelman MS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S45-7. PubMed ID: 1726006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lacidipine, a long-acting calcium antagonist, on hypertension and lipids: a 1 year follow-up.
    Soro S; Ferrara LA
    Eur J Clin Pharmacol; 1991; 41(2):105-7. PubMed ID: 1743241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group.
    Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S35-7. PubMed ID: 1726004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lacidipine, a novel dihydropyridine calcium antagonist, on carbohydrate and lipid metabolism.
    Spieker C; Zidek W
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S23-6. PubMed ID: 8852541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists in hypertension. Proceedings of a symposium. Bangkok, Thailand, February 9, 1990.
    Drugs; 1990; 40 Suppl 2():1-71. PubMed ID: 1982089
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium antagonists ameliorate hypertensive hemodynamic abnormalities. Official satellite symposium of the American Society of Hypertension.
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):153S-206S. PubMed ID: 2751848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.